Clinical Trial Detail

NCT ID NCT02518113
Title A Study of LY3039478 in Combination With Dexamethasone in Participants With T-ALL/T-LBL
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Eli Lilly and Company
Indications

lymphoma

T-cell acute lymphoblastic leukemia

Therapies

Dexamethasone

LY3039478

Age Groups: adult

No variant requirements are available.